North America Molecular Diagnostics Market Projected to Reach $18.13 Billion

Category: Business

Meticulous Research®, a renowned provider of market intelligence solutions, unveils its latest report forecasting the trajectory of the North America Molecular Diagnostics Market. Titled “North America Molecular Diagnostics Market by Product, Test Type, Technology, Application, and End User—Forecast to 2030,” the report anticipates a substantial market value of $18.13 billion by 2030, marking a steady CAGR of 5.3% from 2023 to 2030. Market Overview Molecular diagnostics, which delve into individuals’ health at the molecular level through the analysis of specific genetic sequences, have revolutionized healthcare. Advancements in this field have paved the way for personalized medicine, precision healthcare, and predictive diagnostics. Notably, during the COVID-19 pandemic, molecular diagnostics emerged as pivotal tools, offering rapid and accurate diagnostic solutions. The market encompasses a spectrum of advanced products and technologies, wielded by skilled professionals to enhance patient care. Download Free Sample Report : https://www.meticulousresearch.com/download-sample-report/cp_id=5642 Key Drivers and Challenges The market's growth is underpinned by a multitude of factors, including the burgeoning geriatric population, escalating incidence of communicable and non-communicable diseases, technological innovations in molecular diagnostics, and escalating healthcare expenditures. However, challenges such as regulatory complexities and the high costs associated with molecular diagnostic tests pose hindrances to market expansion. Opportunities and Challenges Despite these challenges, the burgeoning focus on companion diagnostics and the burgeoning popularity of direct-to-consumer (DTC) genetic testing present lucrative growth avenues for market players. Nevertheless, the scarcity of skilled professionals remains a significant obstacle to market growth. Rising Popularity of Direct-to-Consumer Testing Direct-to-consumer genetic testing, characterized by its accessibility and convenience, has gained prominence. These tests, which provide consumers with direct access to their genetic information, bypass the need for healthcare providers. Notable recent developments in this sphere include partnerships between industry players and advancements in regulatory clearances, as exemplified by American Molecular Laboratories (AML) and 1health.io, Inc., and 23andMe, Inc.'s FDA clearance for its hereditary prostate cancer marker test. Browse in depth @ https://www.meticulousresearch.com/product/north-america-molecular-diagnostics-market-5642 Market Segmentation and Insights The report offers a comprehensive segmentation of the North America molecular diagnostics market, analyzing parameters such as product & service, test type, technology, application, end-user, and countries. Noteworthy segments include kits & reagents within the product category, PCR within technology, and laboratory tests within test type. Key Players and Strategies Leading market players, including Hologic, Inc., Danaher Corporation, BioMérieux S.A., Becton, Dickinson and Company, Siemens Healthineers AG, DiaSorin S.p.A., Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche, QIAGEN N.V., and Seegene, Inc., have adopted robust growth strategies to fortify their market presence. Quick Buy @ https://www.meticulousresearch.com/Checkout/62458641 Contact Us: Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research